Pharmacogenetics of the 5-lipoxygenase pathway in asthma

E. Silverman, Kwang Ho In, C. Yandava, J. M. Drazen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

It is now well appreciated that asthma is a chronic inflammatory disease of the airways; among the inflammatory cells that have been implicated in the asthmatic lesion are eosinophils and mast cells. Although these cells have the capacity to produce a number of distinct chemical mediators, the cysteinyl leukotrienes have recently been identified as important mediators of the asthmatic response. The leukotrienes are derived from arachidonic acid released from membrane phospholipids by the action of phospholipases. The archidonic acid so released in the presence of the 5-lipoxygenase (5-LO) activating protein becomes a substrate for the enzyme 5-LO. This enzyme catalyses the stereo-specific addition of molecular oxygen to arachidonic acid to form the product known as leukotriene A4. Leukotriene A4 subsequently becomes a substrate for one of two enzymes, leukotriene A4 epoxide hydrolase or LTC4 synthase. The former catalyses the formation of LTB4 while the later catalyses the formation of the cysteinyl leukotrienes. Thus the enzyme 5-LO is critically posed to serve as a regulator of leukotriene synthesis. 5-LO action is known to be regulated at a number of levels; the mechanisms include regulation of action of the mature protein and regulation of 5-LO gene transcription and translation; there is good reason to believe that all forms of 5-LO regulation are highly interdependent. In this regard we describe the presence and functional consequences of a series of naturally occuring mutations in 5-LO core promoter. These mutations modify gene transcription in vitro, and may have functional consequences in vivo.

Original languageEnglish
Pages (from-to)164-170
Number of pages7
JournalClinical and Experimental Allergy, Supplement
Volume28
Issue number5
Publication statusPublished - 1998 Dec 18
Externally publishedYes

Fingerprint

Arachidonate 5-Lipoxygenase
Pharmacogenetics
Asthma
Leukotriene A4
Leukotrienes
Enzymes
Arachidonic Acid
5-Lipoxygenase-Activating Proteins
Epoxide Hydrolases
Mutation
Leukotriene B4
Phospholipases
Eosinophils
Mast Cells
Genes
Phospholipids
Chronic Disease
Oxygen
Acids
Membranes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Pharmacogenetics of the 5-lipoxygenase pathway in asthma. / Silverman, E.; In, Kwang Ho; Yandava, C.; Drazen, J. M.

In: Clinical and Experimental Allergy, Supplement, Vol. 28, No. 5, 18.12.1998, p. 164-170.

Research output: Contribution to journalArticle

Silverman, E, In, KH, Yandava, C & Drazen, JM 1998, 'Pharmacogenetics of the 5-lipoxygenase pathway in asthma', Clinical and Experimental Allergy, Supplement, vol. 28, no. 5, pp. 164-170.
Silverman, E. ; In, Kwang Ho ; Yandava, C. ; Drazen, J. M. / Pharmacogenetics of the 5-lipoxygenase pathway in asthma. In: Clinical and Experimental Allergy, Supplement. 1998 ; Vol. 28, No. 5. pp. 164-170.
@article{ebb1e309d0a340f08a7c55da1773860f,
title = "Pharmacogenetics of the 5-lipoxygenase pathway in asthma",
abstract = "It is now well appreciated that asthma is a chronic inflammatory disease of the airways; among the inflammatory cells that have been implicated in the asthmatic lesion are eosinophils and mast cells. Although these cells have the capacity to produce a number of distinct chemical mediators, the cysteinyl leukotrienes have recently been identified as important mediators of the asthmatic response. The leukotrienes are derived from arachidonic acid released from membrane phospholipids by the action of phospholipases. The archidonic acid so released in the presence of the 5-lipoxygenase (5-LO) activating protein becomes a substrate for the enzyme 5-LO. This enzyme catalyses the stereo-specific addition of molecular oxygen to arachidonic acid to form the product known as leukotriene A4. Leukotriene A4 subsequently becomes a substrate for one of two enzymes, leukotriene A4 epoxide hydrolase or LTC4 synthase. The former catalyses the formation of LTB4 while the later catalyses the formation of the cysteinyl leukotrienes. Thus the enzyme 5-LO is critically posed to serve as a regulator of leukotriene synthesis. 5-LO action is known to be regulated at a number of levels; the mechanisms include regulation of action of the mature protein and regulation of 5-LO gene transcription and translation; there is good reason to believe that all forms of 5-LO regulation are highly interdependent. In this regard we describe the presence and functional consequences of a series of naturally occuring mutations in 5-LO core promoter. These mutations modify gene transcription in vitro, and may have functional consequences in vivo.",
author = "E. Silverman and In, {Kwang Ho} and C. Yandava and Drazen, {J. M.}",
year = "1998",
month = "12",
day = "18",
language = "English",
volume = "28",
pages = "164--170",
journal = "Clinical and Experimental Allergy, Supplement",
issn = "0960-2178",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",

}

TY - JOUR

T1 - Pharmacogenetics of the 5-lipoxygenase pathway in asthma

AU - Silverman, E.

AU - In, Kwang Ho

AU - Yandava, C.

AU - Drazen, J. M.

PY - 1998/12/18

Y1 - 1998/12/18

N2 - It is now well appreciated that asthma is a chronic inflammatory disease of the airways; among the inflammatory cells that have been implicated in the asthmatic lesion are eosinophils and mast cells. Although these cells have the capacity to produce a number of distinct chemical mediators, the cysteinyl leukotrienes have recently been identified as important mediators of the asthmatic response. The leukotrienes are derived from arachidonic acid released from membrane phospholipids by the action of phospholipases. The archidonic acid so released in the presence of the 5-lipoxygenase (5-LO) activating protein becomes a substrate for the enzyme 5-LO. This enzyme catalyses the stereo-specific addition of molecular oxygen to arachidonic acid to form the product known as leukotriene A4. Leukotriene A4 subsequently becomes a substrate for one of two enzymes, leukotriene A4 epoxide hydrolase or LTC4 synthase. The former catalyses the formation of LTB4 while the later catalyses the formation of the cysteinyl leukotrienes. Thus the enzyme 5-LO is critically posed to serve as a regulator of leukotriene synthesis. 5-LO action is known to be regulated at a number of levels; the mechanisms include regulation of action of the mature protein and regulation of 5-LO gene transcription and translation; there is good reason to believe that all forms of 5-LO regulation are highly interdependent. In this regard we describe the presence and functional consequences of a series of naturally occuring mutations in 5-LO core promoter. These mutations modify gene transcription in vitro, and may have functional consequences in vivo.

AB - It is now well appreciated that asthma is a chronic inflammatory disease of the airways; among the inflammatory cells that have been implicated in the asthmatic lesion are eosinophils and mast cells. Although these cells have the capacity to produce a number of distinct chemical mediators, the cysteinyl leukotrienes have recently been identified as important mediators of the asthmatic response. The leukotrienes are derived from arachidonic acid released from membrane phospholipids by the action of phospholipases. The archidonic acid so released in the presence of the 5-lipoxygenase (5-LO) activating protein becomes a substrate for the enzyme 5-LO. This enzyme catalyses the stereo-specific addition of molecular oxygen to arachidonic acid to form the product known as leukotriene A4. Leukotriene A4 subsequently becomes a substrate for one of two enzymes, leukotriene A4 epoxide hydrolase or LTC4 synthase. The former catalyses the formation of LTB4 while the later catalyses the formation of the cysteinyl leukotrienes. Thus the enzyme 5-LO is critically posed to serve as a regulator of leukotriene synthesis. 5-LO action is known to be regulated at a number of levels; the mechanisms include regulation of action of the mature protein and regulation of 5-LO gene transcription and translation; there is good reason to believe that all forms of 5-LO regulation are highly interdependent. In this regard we describe the presence and functional consequences of a series of naturally occuring mutations in 5-LO core promoter. These mutations modify gene transcription in vitro, and may have functional consequences in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0031766873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031766873&partnerID=8YFLogxK

M3 - Article

C2 - 9988463

AN - SCOPUS:0031766873

VL - 28

SP - 164

EP - 170

JO - Clinical and Experimental Allergy, Supplement

JF - Clinical and Experimental Allergy, Supplement

SN - 0960-2178

IS - 5

ER -